A clinical trial to Compare Two Different Dose of Intratympanic Dexamethasone Injection in Patients of Hearing loss & Ringing Sensation.

Comparison of Different Treatment Plan Using Intratympanic Dexamethasone Injection in Patients of Sensorineural Hearing loss & Tinnitus in Kumaon Region

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054032

Enrollment

140

Registered

2023-06-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H838- Other specified diseases of innerear

Interventions

Intervention1: Intratympanic Dexamethasone (4mg/ml,10mg/ml)injection: 1)Take four different group-(Each group have 35 patients) -In Gp.A give 4mg/ml DXM 1 injection at every 3rd day -Gp.B give 4mg/ml

Eligibility

Inclusion criteria

Inclusion criteria: . All patients of Sensorineural hearing loss ( . All mixed hearing loss patients . Ringing sensation complaining patients

Exclusion criteria

Exclusion criteria: . Presbycusia . CP angle lesion . Patients to lost follow up . Refusal of consent for study . Patients of pure conductive hearing loss

Design outcomes

Primary

Measure	Time frame
PTA after 4weeksTimepoint: PTA after 8weeks	—

Secondary

Measure	Time frame
Ito it all 90-100% hearing improve in 1-2 weeksTimepoint: 1-2 weeks	—

Countries

India

Contacts

Public ContactDr. Shahzad Ahmad

Government medical college haldwani

Drshahzadjnmch85@gmail.com9634623901

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026